Kura Oncology, Inc. 4
4 · Kura Oncology, Inc. · Filed Feb 2, 2016
Insider Transaction Report
Form 4
LIU YI
Chief Scientific Officer
Transactions
- Award
Option to purchase common stock
2016-01-29+50,000→ 50,000 totalExercise: $4.80Exp: 2026-01-28→ Common stock (50,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments commencing on the grant date.